DHR

Danaher Stock Price

183.70
0.03 (0.02%)
Upgrade to Real-Time
Afterhours (Closed)
183.67
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Danaher Corporation DHR NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-1.80 -0.97% 183.67 182.80 185.85 185.53 185.47 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
21,925 1,959,307 $ 183.75 $ 360,016,294 2,700,856 119.60 - 187.19
Last Trade Time Type Quantity Stock Price Currency
19:21:14 1 $ 183.70 USD

Danaher Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 129.86B 707.02M 627.47M $ 17.91B $ 3.72B 4.05 40.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
6.74M $ 0.68 0.37% - -

more financials information »

Danaher News

Date Time Source News Article
7/09/202011:00Business WireFully Integrated SCIEX OS Software Launches at Virtual..
6/29/202008:46Dow Jones NewsDanaher Unit's SARS-CoV-2 IgG Antibody Test Gets FDA..
6/29/202008:00PR Newswire (US)Beckman Coulter's SARS-CoV-2 IgG Antibody Test Receives FDA..
6/15/202003:00PR Newswire (US)Beckman Coulter's SARS-CoV-2 IgG antibody test now available..
6/12/202016:25Edgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)
6/10/202007:31Edgar (US Regulatory)Current Report Filing (8-k)
6/09/202007:00PR Newswire (US)Cepheid Announces Development of Four-in-One Combination..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DHR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week182.00187.19181.41183.762,219,3411.670.92%
1 Month167.75187.19165.25175.282,464,61515.929.49%
3 Months158.28187.19151.365166.393,073,57725.3916.04%
6 Months158.24187.19119.60154.213,370,38525.4316.07%
1 Year142.73187.19119.60149.524,992,74040.9428.68%
3 Years83.11187.1978.97128.803,166,192100.56121.0%
5 Years86.45187.199.52113.732,954,17997.22112.46%

Danaher Description

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which adds to its life sciences segment.
Your Recent History
NYSE
DHR
Danaher
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200711 12:39:38